
Unlocking Anbio’s IPO: A Pivotal Shift in Global Diagnostics
Anbio Biotechnology’s IPO is priced at $5.00 per share, aiming to raise $8 million on February 19, 2025, under the symbol NNNN. The IPO is geared towards enhancing sales, distribution networks, advanced R&D, and working capital. Supported by AC Sunshine Securities, the